赛诺医疗：股东郭彦超拟减持不超过约17万股

Group 1 - The core point of the announcement is that Guo Yanchao, a major shareholder of Sino Medical, holds approximately 20.84 million shares, accounting for 5.01% of the total shares of the company [1] - Of the shares held, 20.5 million shares were acquired through a private transfer agreement in January 2024, representing 4.93% of the total shares, while about 340,000 shares were purchased through the secondary market, accounting for 0.08% [1] - Guo Yanchao plans to reduce his holdings by no more than approximately 170,000 shares, which is up to 0.04% of the total share capital, within three months after the announcement of the reduction plan [1] Group 2 - As of the announcement date, Sino Medical's revenue composition for the year 2024 is 99.83% from the medical device industry and 0.17% from other businesses [1] - The market capitalization of Sino Medical is reported to be 13.3 billion yuan [2]